Among them, CD133 serves as a key marker for various cancer CSCs, with its expression level negatively correlated with the degree of cell differentiation, which is crucial for maintaining stem cell properties and driving tumor progression [43, 44]. The gene discussed is PROM1; the disease is neoplasm.